Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Sanofi - American Depositary Shares (NQ: SNY )

57.75 +0.06 (+0.10%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Sanofi - American Depositary Shares

< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
33 34 Next >
AstraZeneca's COVID-19 Antibody Cocktail, RSV Treatment For Infants Gets European Authority Backing
Via Benzinga
ASLAN Pharma Starts Eblasakimab Program In Dupixent Treated Dermatitis Patients
Via Benzinga
Regeneron-Sanofi Eczema Drug Shows Improvements In Itchy Inflammatory Skin Disease
Via Benzinga
Sanofi-GSK COVID-19 Vaccine May See European Approval Soon: Report
Via Benzinga
Sanofi-Regeneron's Flagship Drug Shows Consistent Efficacy, Safety Profile At Two Years For Asthma In Kids
Via Benzinga
Top Financial Stories Thursday, September 1: Netflix Weighs Charging High Sum For Ads, Self Harm posts Grow On Twitter, California Fast-Food Bill Faces Industry Backlash...
Wall Street Journal 
Via Benzinga
Sanofi's Rare Disease Drug Xenpozyme Scores FDA Approval
Via Benzinga
Bluebird bio Seeks Back-to-Back Nods, 'Go' or 'No-Go' For Revance's Botox Rival, Amylyx' Twin Hurdles And More: September's Key PDUFA Catalysts Biotech Investors Must Know
After August’s mixed tally for Food and Drug Administration approvals, investors turn to a new month, which has a fairly loaded calendar. 
Via Benzinga
With Approval For Dengue Vaccine, Takeda May Find It Challenging To Compete Bigger Rivals: Report
Via Benzinga
Sanofi's Hemophilia Candidate Goes Under Priority FDA Review
Via Benzinga
TG Therapeutics Touts Encouraging Data From Multiple Sclerosis Candidate
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  On Thursday, 63 companies set new 52-week lows. 
Via Benzinga
Upstart Digital Health Company, DarioHealth, Announces Significant Contract with National Health Plan Provider, Giving Millions Access to Mental Health Resources
DarioHealth Corp. (NASDAQ: DRIO) recently announced 
Via Benzinga
MarketBeat: Week in Review 8/15 - 8/19
The economic reports continue to signal volatility. You can count on MarketBeat analysts to bring you the stocks and stories that are driving the market. 
Via MarketBeat
Topics Economy Workforce
Exposures Economy Interest Rates Layoff
Is Sanofi A Buy, Despite Recent Stumbles?
Pharmaceuticals are subject to whiplash trade. That's evident with sharp moves lower in Sanofi, GSK and Teva on news about clinical trials and legal actions. 
Via MarketBeat
Topics Intellectual Property
Exposures Intellectual Property
Millions Suffering From Diabetes May Soon See Relief From Some Of The Pain And Expenses Associated
By Mark Gilman -- Benzinga 
Via News Direct
Exposures Product Safety
Millions Suffering From Diabetes May Soon See Relief From Some Of The Pain And Expenses Associated
Americans with diabetes have been relying on insulin injections to manage their illness for decades. Those injections can be painful, expensive and inconvenient. The daily invasive testing regimen adds... 
Via TheNewswire.com
Exposures Product Safety
Sanofi's Breast Cancer Drug Fallout 'Creates Buying Opportunity' For This Stock
According to Oppenheimer analyst, the fallout of Sanofi SA's (NASDAQ: SNY) amcenestrant creates a buying opportunity for Arvinas Inc (NASDAQ: ARVN)  
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  During Thursday's trading, 62 companies set new 52-week lows. 
Via Benzinga
Millions Suffering From Diabetes May Soon See Relief From Some Of The Pain And Expenses Associated
Americans with diabetes have been relying on insulin injections to manage their illness for decades. Those injections can be painful, expensive and inconvenient. The daily invasive testing regimen adds... 
Via Benzinga
This Healthcare Stock Dipped Over 30%; Here Are 83 Biggest Movers From Yesterday
Gainers 
Via Benzinga
Sanofi Earns Price Target Cut After Stopping Breast Cancer Drug Trial
Via Benzinga
Sanofi, Children's Place And Some Other Big Stocks Moving Lower On Wednesday
  Embark Technology, Inc. (NASDAQ: EMBK) fell 25.1% to $12.40. Embark Technology reported the completion of reverse stock split. 
Via Benzinga
Sanofi's Run Of Bad Luck Continues As Pharma Giant Tosses Out A Cancer Drug
Shares extended deep losses following a Zantac-inspired downturn last week. 
Via Investor's Business Daily
Benzinga Before The Bell: More Amazon Workers Join Union Over Pay and Work Conditions, UK Inflation Highest In 40 Years, Sole Monkeypox Vaccine Maker Finds It Difficult To Meet Accelerating Demand And Other Top Financial Stories Wednesday, August 17
CNBC BlackRock To Pledge A$1B In Australian Battery Storage Assets – Report 
Via Benzinga
Why Blue Water Vaccines Is Trading Higher By Around 80%, Here Are 61 Stocks Moving In Wednesday's Mid-Day Session
Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 79.5% to $4.57 after the company announced it plans to explore the potential development of a novel monkeypox vaccine using its norovirus... 
Via Benzinga
Sanofi Ends Development Of Breast Cancer Drug Amcenestrant After Trial Failure
Via Benzinga
Why Hill International Shares Are Trading Higher By 58%: Here Are 25 Stocks Moving Premarket
Gainers Hill International, Inc. (NYSE: HIL) shares rose 58.1% to $2.75 in pre-market trading after the company agreed to be acquired by Global Infrastructure Solutions Inc. for $2.85 per share. 
Via Benzinga
Do I Need to Get A Polio Vaccine? New York Sewer Discovery Triggers Fears About Paralysis-Inducing Virus
New York officials have detected polio in the city's wastewater, suggesting the virus has been circulating in the local area. 
Via Benzinga
Recalled Heartburn Pill Zantac Sets Fire To Glaxo and Sanofi Shares As Billions In Market Value Goes Up In Smoke
Sanofi SA (NASDAQ: SNY), GSK Plc (NYSE: GSK), and Haleon Plc (NYSE: HLN) have lost a combined $40 billion in mar 
Via Benzinga
< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
33 34 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.